Berger Montague Settles Whistleblower Lawsuit Involving AstraZeneca, Cephalon, & BioGen, Inc.; Secures $55 Million on Behalf of Taxpayers

AstraZeneca, Cephalon, Inc., and BioGen, Inc. have agreed to pay $55 million to settle allegations of unlawful billing practices with regard to Medicaid prescriptions. As one of the leading and most successful whistleblower law firms in the United States, Berger Montague is pleased to announce its involvement in [...]

By | 2018-03-25T13:25:32+00:00 August 13th, 2015|Healthcare Fraud|